MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

CPI Training for Parents of Children With ASD

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Behavioral: Parent-based Crisis Prevention Institute (CPI) physical management training program (P-CPI)

First Posted Date: 2018-05-25

Last Posted Date: 2021-06-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 81

Registration Number: NCT03537261

Locations: 🇺🇸
Lurie Center for Autism, Lexington, Massachusetts, United States

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

Phase 1

Recruiting

Conditions: Pulmonary Fibrosis
Lung Cancer

Interventions: Drug: [68Ga]CBP8
Diagnostic Test: PET Imaging

First Posted Date: 2018-05-24

Last Posted Date: 2025-01-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 100

Registration Number: NCT03535545

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients

Not Applicable

Recruiting

Conditions: Gastroparesis

Interventions: Behavioral: Cognitive Behavioral Therapy

First Posted Date: 2018-05-21

Last Posted Date: 2024-01-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 29

Registration Number: NCT03531450

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Patient Receptiveness to Using Virtual Reality

Completed

Conditions: Anxiety
Pain

First Posted Date: 2018-05-18

Last Posted Date: 2021-02-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 89

Registration Number: NCT03528668

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Application of IV 99mTc-tilmanocept for Imaging of Macrophage-specific Inflammation

Completed

Conditions: HIV

Interventions: Diagnostic Test: Imaging

First Posted Date: 2018-05-14

Last Posted Date: 2021-02-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 9

Registration Number: NCT03523130

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Screening for Atrial Fibrillation Among Older Patients in Primary Care Clinics

Not Applicable

Conditions: Atrial Fibrillation

Interventions: Diagnostic Test: Single lead handheld electrocardiogram

First Posted Date: 2018-05-03

Last Posted Date: 2021-02-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35308

Registration Number: NCT03515057

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

IDH2 Inhibition Using Enasidenib as Maintenance Therapy for IDH2-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation

Phase 1

Completed

Conditions: Acute Myeloid Leukemia
Chronic Myelomonocytic Leukemia

Interventions: Drug: Enasidenib

First Posted Date: 2018-05-03

Last Posted Date: 2024-03-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 23

Registration Number: NCT03515512

Locations: 🇺🇸
Johns Hopkins Cancer Center, Baltimore, Maryland, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

and more 1 locations

Tau/P-Tau and Neurocognitive Outcomes in Children

Conditions: General Anesthetics Toxicity
Postoperative Cognitive Dysfunction
Child Development

First Posted Date: 2018-04-30

Last Posted Date: 2022-04-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT03511729

Locations: 🇺🇸
Zhongcong Xie, Boston, Massachusetts, United States
🇺🇸
Boston Childrens Hospital, Boston, Massachusetts, United States

EEG Studies of Sevoflurane-Induced General Anesthesia

Phase 2

Completed

Conditions: Anesthesia

Interventions: Drug: Sevoflurane
Drug: Ketamine

First Posted Date: 2018-04-20

Last Posted Date: 2019-10-24

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 12

Registration Number: NCT03503578

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness

Completed

Conditions: Brain Injuries, Traumatic
Consciousness Disorder
Coma

First Posted Date: 2018-04-20

Last Posted Date: 2024-08-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 79

Registration Number: NCT03504709

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy